Latest News
-

Exercise increases cellular recycling
⏱️ 5 min read
Exercise boosts cellular recycling in mice. Could this be why exercise is also good for HD – or even help develop dru
-

The HDBuzz Prize for young science writers
⏱️ 3 min read
Announcing the HDBuzz Prize for young science writers!
-

What's the connection between Huntington's Disease and cancer?
⏱️ 6 min read
HD patients are less likely to get cancer, according to a study from Sweden – what does this mean?
-

Closing the care gap: new guidelines for HD care
⏱️ 6 min read
Closing the care gap: new guidelines to help every Huntington's disease patient get great care
-

Stem-cell neurons make the right connections
⏱️ 7 min read
Replacing neurons in mice with stem cells works much better than expected, suggesting that replacement therapy might
-

2012 Therapeutics Conference: a retrospective
⏱️ 19 min read
HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference
-

Mutant yeast highlights crucial CAG-reading protein
⏱️ 5 min read
A new job for a DNA-reading protein called SPT4 – controlling the balance of mutant and healthy huntingtin protein
-

HD Therapeutics Conference 2012 Updates: Day 3
⏱️ 6 min read
Day 3 of our coverage of the Huntington's Disease Therapeutics Conference
-

HD Therapeutics Conference 2012 Updates: Day 2
⏱️ 4 min read
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-

HD Therapeutics Conference 2012 Updates: Day 1
⏱️ 5 min read
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
“A Whole World of Unknown”: How Couples Live Between Today and Tomorrow with HD
-
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
-
Skyhawk’s drug trial takes flight in the US
-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
